Mizoribine Hydrobromide

BGC Id:	724257619784
CAS No:	50924-49-7
Synonyms:	bredinine ; mizoribine, >=99% ; b-bredinin ; mizorbine ; nsc 289637 ; brn 4151713 ; mizoribine ; he 69 ; bredinin ; mizoribina
Molecular Formula:	C9H13N3O6
Molecular Weight:	259.22
EINECS:

What other providers are available for CAS 50924-49-7?

Identify

Synonyms:

bredinine ; mizoribine, >=99% ; b-bredinin ; mizorbine ; nsc 289637 ; brn 4151713 ; mizoribine ; he 69 ; bredinin ; mizoribina

CAS:

50924-49-7

EINECS:

Molecular Formula:

C9H13N3O6

MDL:

MFCD00057221

Properties

Molecular Weight:

259.22 g·mol−1

Density:

2.06 g/cm³ (Predicted)

Melting point:

>2000C

Boiling point:

755.87 °C at 760 mmHg (Predicted)

Safety Information

Hazard Symbols: T

Europe standard Hazard pictograms, code and definition

Hazard Classes:

Risk Codes:

46-60-61-36/37/38 (R)

Safety Codes:

53-22-26-36/37/39-45 (S)

WGK Germany:

RTECS:

NI3980000

Storage temperature:

2-8°C

The following providers cannot be verified precisely. The companies have offered the product in the past, but despite all care, the companies could not confirm it 100 percent!

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc. now offers over 140,000 specialty biochemicals under our ChemCruz™ brand. Santa Cruz Biotechnology, Inc. is focused... Request

What other providers are available for CAS 50924-49-7?

In addition to the providers presented here for Mizoribine Hydrobromide with the CAS number 50924-49-7, there are other 53 providers with slightly different product names available for this CAS number.

Bredinin

+2 additional providers that we know from the past

Mizoribine

5-Hydroxy-1-beta-D-ribofuranosyl-1H-imidazole-4-carboxamide

+4 additional providers that we know from the past

N'-(beta-D-Ribofuranosyl)-5-hydroxyimidazole-4-carboxamide, mizoribine, bredinin

+1 additional providers that we know from the past

1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-hydroxy-1H-imidazole-4-carboxamide

BLD Pharmatech Ltd | BuGuCh & Partners +1 additional providers that we know from the past